Linsley; Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Linsley; Peter.The latest application filed is for "oligonucleotides for treating expanded repeat diseases".
- Linsley; Peter - Seattle WA
- Linsley; Peter - San Francisco CA
- Linsley; Peter - Mountain View CA
- Linsley; Peter - San Diego CA
- Linsley; Peter - Settle WA
- Linsley; Peter - Encinitas CA
| Patent | Date |
|---|---|
| Induced exon inclusion in spinal muscle atrophy Grant 10,577,605 - Linsley , et al. | 2020-03-03 |
| Oligonucleotides For Treating Expanded Repeat Diseases App 20190100755 - Linsley; Peter ; et al. | 2019-04-04 |
| Induced Exon Inclusion In Spinal Muscle Atrophy App 20180273954 - Linsley; Peter ; et al. | 2018-09-27 |
| Oligonucleotides for treating expanded repeat diseases Grant 10,066,228 - Linsley , et al. September 4, 2 | 2018-09-04 |
| Induced exon inclusion in spinal muscle atrophy Grant 9,944,926 - Linsley , et al. April 17, 2 | 2018-04-17 |
| Previewing search results Grant 9,727,587 - Linsley , et al. August 8, 2 | 2017-08-08 |
| Query classification Grant 9,152,701 - Linsley October 6, 2 | 2015-10-06 |
| Image-centric documents Grant 9,135,317 - Linsley September 15, 2 | 2015-09-15 |
| Query Classification App 20150169739 - Linsley; Peter | 2015-06-18 |
| Image-centric Documents App 20150161218 - LINSLEY; Peter | 2015-06-11 |
| Microrna Compositions And Methods App 20150087607 - Marcusson; Eric G. ; et al. | 2015-03-26 |
| Induced Exon Inclusion In Spinal Muscle Atrophy App 20140329772 - Linsley; Peter ; et al. | 2014-11-06 |
| Oligonucleotides For Treating Expanded Repeat Diseases App 20140303238 - Linsley; Peter ; et al. | 2014-10-09 |
| MicroRNA compositions and methods Grant 8,846,631 - Marcusson , et al. September 30, 2 | 2014-09-30 |
| Previewing Search Results App 20140149398 - Linsley; Peter ; et al. | 2014-05-29 |
| Identification of websites that break out of frames Grant 8,713,172 - Linsley April 29, 2 | 2014-04-29 |
| Previewing search results Grant 8,645,360 - Linsley , et al. February 4, 2 | 2014-02-04 |
| Microrna Compositions And Methods App 20130123329 - Marcusson; Eric G. ; et al. | 2013-05-16 |
| Previewing Search Results App 20130117258 - Linsley; Peter ; et al. | 2013-05-09 |
| Methods Of Using Mir210 As A Biomarker For Hypoxia And As A Therapeutic Agent For Treating Cancer App 20110166200 - Zhang; Zhan ; et al. | 2011-07-07 |
| Methods and Compositions for Treating Cancer App 20100166731 - Bartz; Steven R. ; et al. | 2010-07-01 |
| Isolated Nucleic Acid Molecules Corresponding To Micro Rna 145 (mirna-145) And Their Use In Treating Colon Cancer App 20100113577 - Shi; Bin ; et al. | 2010-05-06 |
| Method for indentifying modulators of PPIL2 useful for treating Alzheimer's disease App 20070048320 - Espeseth; Amy ; et al. | 2007-03-01 |
| Monoclonal antibodies for treatment of human non-small cell lung carcinomas Grant 5,091,177 - Hellstrom , et al. February 25, 1 | 1992-02-25 |
| Monoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomas Grant 4,935,495 - Hellstrom , et al. June 19, 1 | 1990-06-19 |
| Monocolonal antibodies and antigen for human non-small cell lung carcinomas Grant 4,906,562 - Hellstrom , et al. March 6, 1 | 1990-03-06 |
| Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies Grant 4,873,188 - Hellstrom , et al. October 10, 1 | 1989-10-10 |
| Monoclonal antibodies for human non-small cell lung carinomas Grant 4,737,579 - Hellstrom , et al. April 12, 1 | 1988-04-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 